SAB BIOTHERAPEUTICS, INC. (SABSW) Net margin 2020–2024
SAB BIOTHERAPEUTICS, INC. (SABSW) net profit margin by fiscal year — reported net income divided by reported revenue.
-2579.0%FY2024 · since FY2020: 36.4% → -2579.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -2579.0% | -694.5 pp |
| FY2023 | -1884.5% | -1806.1 pp |
| FY2022 | -78.4% | -50.2 pp |
| FY2021 | -28.2% | -64.6 pp |
| FY2020 | 36.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Gross profitSABSW Gross marginSABSW Operating incomeSABSW Operating marginSABSW Operating cash flowSABSW Free cash flowSABSW Capital expendituresSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Total liabilitiesSABSW Shareholders’ equitySABSW overview →